Assessment of tumor size as a useful marker for the surgical staging of endometrial cancer

Oncology Reports

Volumn 31, Issue 5, 2014, Pages 2407-2412

  Berretta, Roberto ^a   Patrelli, Tito Silvio ^a   Migliavacca, Costanza ^a   Rolla, Martino ^a   Franchi, Laura ^a   Monica, Michela ^a   Modena, Alberto Bacchi ^a   Gizzo, Salvatore ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Endometrial cancer; Pelvic lymphadenectomy; Prognostic factors; Tumor markers; Tumor volume size

Indexed keywords

CA 125 ANTIGEN; MEMBRANE PROTEIN; MUC16 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; ENDOMETRIUM CANCER; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; TREATMENT INDICATION; TUMOR VOLUME; BLOOD; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; HYSTERECTOMY; LYMPH NODE; PATHOLOGY;

CA-125 ANTIGEN; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODES; LYMPHATIC METASTASIS; MEMBRANE PROTEINS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84898622215     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3108     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011
2. Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Sessa C; ESMO Guidelines Working Group: Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 22 (Suppl 6): 35-39, 2011
3. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E and Vergote I: Endometrial cancer. Lancet 366: 491-505, 2005
4. Patrelli TS, Berretta R, Rolla M, Vandi F, Capobianco G, Gramellini D, Bacchi Modena A and Nardelli GB: Pelvic lymphadenectomy in endometrial cancer: Our current experience. Eur J Gynaecol Oncol 30: 536-538, 2009
5. Zhang C, Wang C and Feng W: Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma. Int J Gynecol Cancer 22: 1373-1377, 2012
6. Mariani A, Webb MJ, Keeney GL and Podratz KC: Routes of lymphatic spread: A study of 112 consecutive patients with endometrial cancer. Gynecol Oncol 81: 100-104, 2001
7. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD and Graham JE: Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 40: 55-65, 1991
8. Berretta R, Merisio C, Piantelli G, Rolla M, Giordano G, Melpignano M and Nardelli GB: Preoperative transvaginal ultrasonography and intraoperative gross examination for assessing myometrial invasion by endometrial cancer. J Ultrasound Med 27: 349-355, 2008
9. Al Kushi A, Lim P, Aquino-Parsons C and Gilks CB: Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium. Mod Pathol 15: 365-371, 2002
10. Nofech-Mozes S, Ackerman I, Ghorab Z, Ismiil N, Thomas G, Covens A and Khalifa MA: Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma. Am J Clin Pathol 129: 912-917, 2008
11. Merisio C, Berretta R, De Ioris A, Pultrone DC, Rolla M, Giordano G, Tateo S and Melpignano M: Endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia. Eur J Obstet Gynecol Reprod Biol 122: 107-111, 2005
12. Di Cristofano A and Ellenson LH: Endometrial carcinoma. Annu Rev Pathol 2: 57-85, 2007
13. Gu M, Shi W, Barakat RR, Thaler HT and Saigo PE: Peritoneal washings in endometrial carcinoma. A study of 298 patients with histopathologic correlation. Acta Cytol 44: 783-789, 2000
14. Turner DA, Gershenson DM, Atkinson N, Sneige N and Wharton AT: The prognostic significance of peritoneal cytology for stage I endometrial cancer. Obstet Gynecol 74: 775-780, 1989
15. Hanson MB, van Nagell JR Jr., Powell DE, Donaldson ES, Gallion H, Merhige M and Pavlik EJ: The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer 55: 1753-1757, 1985
16. Gizzo S, Di Gangi S, Bertocco A, Noventa M, Fagherazzi S, Ancona E, Saccardi C, Patrelli TS, D'Antona D and Nardelli GB: Levonorgestrel intrauterine system in adjuvant tamoxifen treatment: Balance of breast risks and endometrial benefits systematic review of literature. Reprod Sci: Sep 23, 2013 (Epub ahead of print)
17. Wright JD, Barrena Medel NI, Sehouli J, Fujiwara K and Herzog TJ: Contemporary management of endometrial cancer. Lancet 379: 1352-1360, 2012
18. ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C and Parmar MK: Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study. Lancet 373: 125-136, 2009
19. Patrelli TS, Silini EM, Gizzo S, Berretta R, Franchi L, Thai E, Lukanovic A, Nardelli GB and Modena AB: Extragenital Müllerian adenosarcoma with pouch of Douglas location. BMC Cancer 11: 171, 2011
20. Patrelli TS, Gizzo S, Di Gangi S, Guidi G, Rondinelli M and Nardelli GB: Cervical Mullerian adenosarcoma with heterologous sarcomatous overgrowth: A fourth case and review of literature. BMC Cancer 11: 236, 2011
21. Savelli L, Testa AC, Mabrouk M, Zannoni L, Ludovisi M, Seracchioli R, Scambia G and De Iaco P: A prospective blinded comparison of the accuracy of transvaginal sonography and frozen section in the assessment of myometrial invasion in endometrial cancer. Gynecol Oncol 124: 549-552, 2012
22. Savelli L, Ceccarini M, Ludovisi M, Fruscella E, De Iaco PA, Salizzoni E, Mabrouk M, Manfredi R, Testa AC and Ferrandina G: Preoperative local staging of endometrial cancer: Transvaginal sonography vs. magnetic resonance imaging. Ultrasound Obstet Gynecol 31: 560-566, 2008
23. Schink JC, Rademaker AW, Miller DS and Lurain JR: Tumor size in endometrial cancer. Cancer 67: 2791-2794, 1991
24. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G and Podratz KC: Low-risk corpus cancer: Is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 182: 1506-1519, 2000
25. Sorosky JI: Endometrial cancer. Obstet Gynecol 111: 436-447, 2008
26. Patrelli TS, Berretta R, Gizzo S, Pezzuto A, Franchi L, Lukanovic A, Nardelli GB and Modena AB: CA 125 serum values in surgically treated endometriosis patients and its relationships with anatomic sites of endometriosis and pregnancy rate. Fertil Steril 95: 393-396, 2011
27. Gizzo S, Ancona E, Saccardi C, D'Antona D, Nardelli GB and Plebani M: Could kidney glomerular filtration impairment represent the "Achilles heel" of HE4 serum marker? A possible further implication. Clin Chem Lab Med 52: E45-e46, 2014
28. Gusberg SB, Jones HC Jr. and Tovell HM: Selection of treatment for corpus cancer. Am J Obstet Gynecol 80: 374-380, 1960
29. Johnsson JE: Recurrences and metastases in carcinoma of the uterine body correlated to the size and localization of the primary tumor. Acta Obstet Gynecol Scand 58: 405-408, 1979
30. Schink JC, Lurain JR, Wallemark CB and Chmiel JS: Tumor size in endometrial cancer: A prognostic factor for lymph node metastasis. Obstet Gynecol 70: 216-219, 1987
31. Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC and Miller DS: Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 78: 63-69, 1991
32. Milam MR, Java J, Walker JL, Metzinger DS, Parker LP, Coleman RL; Gynecologic Oncology Group: Nodal metastasis risk in endometrioid endometrial cancer. Obstet Gynecol 119: 286-292, 2012
33. Saccardi C, Gizzo S, Patrelli TS, Ancona E, Anis O, Di Gangi S, Vacilotto A, D'Antona D and Nardelli GB: Endometrial surveillance in tamoxifen users: Role, timing and accuracy of hysteroscopic investigation: Observational longitudinal cohort study. Endocr Relat Cancer 20: 455-462, 2013